Applications of the Keap1-Nrf2 system for gene and cell therapy

Free Radical Biology and Medicine

Volumn 88, Issue Part B, 2015, Pages 350-361

  Kanninen, Katja M ^a   Pomeshchik, Yuriy ^a   Leinonen, Hanna ^a   Malm, Tarja ^a   Koistinaho, Jari ^a   Levonen, Anna Liisa ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cancer; Gene therapy; Neurodegenerative diseases; Nrf2; Spinal cord injury; Stem cell therapy; Transcription factor

Indexed keywords

ADENOVIRUS VECTOR; KELCH LIKE ECH ASSOCIATED PROTEIN 1; LENTIVIRUS VECTOR; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; SIGNAL PEPTIDE;

ADIPOSE DERIVED STEM CELL; AGING; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CENTRAL NERVOUS SYSTEM DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; ENHANCER REGION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE THERAPY; HUMAN; INDUCED PLURIPOTENT STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEOPLASM; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TARGETING; RADIOSENSITIVITY; STEM CELL SELF-RENEWAL; STEM CELL TRANSPLANTATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ANIMAL; GENETICS; METABOLISM; NEOPLASMS; NEURODEGENERATIVE DISEASES; PHYSIOLOGY; PROCEDURES;

ANIMALS; GENETIC THERAPY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS; NEURODEGENERATIVE DISEASES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; STEM CELL TRANSPLANTATION;

EID: 84971003205     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.06.037     Document Type: Review

References (211)

1. J.M. Lee, J. Li, D.A. Johnson, T.D. Stein, A.D. Kraft, M.J. Calkins, R.J. Jakel, and J.A. Johnson Nrf2, a multi-organ protector? FASEB J. 19 2005 1061 1066
2. M. Zhang, C. An, Y. Gao, R.K. Leak, J. Chen, and F. Zhang Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection Prog. Neurobiol. 100 2013 30 47
3. K. Kanninen, R. Heikkinen, T. Malm, T. Rolova, S. Kuhmonen, H. Leinonen, S. Yla-Herttuala, H. Tanila, A.L. Levonen, M. Koistinaho, and J. Koistinaho Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of alzheimer disease Proc. Natl. Acad. Sci. USA 106 2009 16505 16510
4. C.Y. Wang, Z.Y. Wang, J.W. Xie, J.H. Cai, T. Wang, Y. Xu, X. Wang, and L. An CD36 upregulation mediated by intranasal LV-Nrf2 treatment mitigates hypoxia-induced progression of alzheimer-like pathogenesis Antioxid. Redox Signal. 21 2014 2208 2230
5. K. Kanninen, T.M. Malm, H.K. Jyrkkanen, G. Goldsteins, V. Keksa-Goldsteine, H. Tanila, M. Yamamoto, S. Yla-Herttuala, A.L. Levonen, and J. Koistinaho Nuclear factor erythroid 2-related factor 2 protects against beta amyloid Mol. Cell. Neurosci. 39 2008 302 313
6. H.M. Leinonen, E. Kansanen, P. Polonen, M. Heinaniemi, and A.L. Levonen Role of the Keap1-Nrf2 pathway in cancer Adv. Cancer Res. 122 2014 281 320
7. A.L. Levonen, B.G. Hill, E. Kansanen, J. Zhang, and V.M. Darley-Usmar Redox regulation of antioxidants, autophagy, and the response to stress: Implications for electrophile therapeutics Free Radic. Biol. Med. 71 2014 196 207
8. D. Ren, N.F. Villeneuve, T. Jiang, T. Wu, A. Lau, H.A. Toppin, and D.D. Zhang Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism Proc. Natl. Acad. Sci. USA 108 2011 1433 1438
9. L. Vannucci, M. Lai, F. Chiuppesi, L. Ceccherini-Nelli, and M. Pistello Viral vectors: a look back and ahead on gene transfer technology New Microbiol. 36 2013 1 22
10. J.G. Smith, C.M. Wiethoff, P.L. Stewart, and G.R. Nemerow Adenovirus Curr. Top. Microbiol. Immunol. 343 2010 195 224
11. M. Reeh, M. Bockhorn, D. Gorgens, M. Vieth, T. Hoffmann, R. Simon, J.R. Izbicki, G. Sauter, U. Schumacher, and M. Anders Presence of the coxsackievirus and adenovirus receptor (CAR) in human neoplasms: a multitumour array analysis Br. J. Cancer 109 2013 1848 1858
12. T.B. Lewis, J.N. Glasgow, A.M. Glandon, D.T. Curiel, and D.G. Standaert Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy PLoS One 5 2010 10.1371/journal.pone.0012672
13. A. Persson, X. Fan, B. Widegren, and E. Englund Cell type- and region-dependent coxsackie adenovirus receptor expression in the central nervous system J. Neurooncol. 78 2006 1 6
14. C. Capasso, M. Garofalo, M. Hirvinen, and V. Cerullo The evolution of adenoviral vectors through genetic and chemical surface modifications Viruses 6 2014 832 855
15. A. Follenzi, and L. Naldini HIV-based vectors. preparation and use Methods Mol. Med. 69 2002 259 274
16. F.J. Leyva, J.J. Anzinger, J.P. McCoy Jr, and H.S. Kruth Evaluation of transduction efficiency in macrophage colony-stimulating factor differentiated human macrophages using HIV-1 based lentiviral vectors BMC Biotechnol. 11 2011 13-6750-11-13
17. D. Trono Lentiviral vectors: turning a deadly foe into a therapeutic agent Gene Ther. 7 2000 20 23
18. N. al Yacoub, M. Romanowska, N. Haritonova, and J. Foerster Optimized production and concentration of lentiviral vectors containing large inserts J. Gene Med. 9 2007 579 584
19. T.B. Lentz, S.J. Gray, and R.J. Samulski Viral vectors for gene delivery to the central nervous system Neurobiol. Dis. 48 2012 179 188
20. M.A. Kotterman, and D.V. Schaffer Engineering adeno-associated viruses for clinical gene therapy Nat. Rev. Genet. 15 2014 445 451
21. C. Burger, K. Nash, and R.J. Mandel Recombinant adeno-associated viral vectors in the nervous system Hum. Gene Ther. 16 2005 781 791
22. S. Yla-Herttuala Endgame: Glybera finally recommended for approval as the first gene therapy drug in the european union Mol. Ther. 20 2012 1831 1832
23. R.J. Lee, M.L. Springer, W.E. Blanco-Bose, R. Shaw, P.C. Ursell, and H.M. Blau VEGF gene delivery to myocardium: deleterious effects of unregulated expression Circulation 102 2000 898 901
24. M.L. Springer, A.S. Chen, P.E. Kraft, M. Bednarski, and H.M. Blau VEGF gene delivery to muscle: potential role for vasculogenesis in adults Mol. Cell 2 1998 549 558
25. C. Rinsch, E. Regulier, N. Deglon, B. Dalle, Y. Beuzard, and P. Aebischer A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension Hum. Gene Ther. 8 1997 1881 1889
26. G.L. Semenza Hypoxia-inducible factor 1 and cardiovascular disease Annu. Rev. Physiol. 76 2014 39 56
27. H. Hurttila, J.K. Koponen, E. Kansanen, H.K. Jyrkkanen, A. Kivela, R. Kylatie, S. Yla-Herttuala, and A.L. Levonen Oxidative stress-inducible lentiviral vectors for gene therapy Gene Ther 15 2008 1271 1279
28. L.L. Policastro, I.L. Ibanez, H.A. Duran, G. Soria, V. Gottifredi, and O.L. Podhajcer Suppression of cancer growth by nonviral gene therapy based on a novel reactive oxygen species-responsive promoter Mol. Ther. 17 2009 1355 1364
29. G.U. Dachs, A.V. Patterson, J.D. Firth, P.J. Ratcliffe, K.M. Townsend, I.J. Stratford, and A.L. Harris Targeting gene expression to hypoxic tumor cells Nat. Med 3 1997 515 520
30. G. Cai, X. Nie, P. Guo, Z. Guan, J. Zhang, and Q. Shen A new inducible adenoviral expression system that responds to inflammatory stimuli in vivo J. Gene Med. 8 2006 1369 1378
31. T. Shibata, A.J. Giaccia, and J.M. Brown Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy Neoplasia 4 2002 40 48
32. T.J. Harvey, I.M. Hennig, S.D. Shnyder, P.A. Cooper, N. Ingram, G.D. Hall, P.J. Selby, and J.D. Chester Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo Cancer Gene Ther. 18 2011 773 784
33. L. Marignol, R. Foley, T.D. Southgate, M. Coffey, D. Hollywood, and M. Lawler Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro J. Gene Med. 11 2009 169 179
34. A.S. Pachori, L.G. Melo, M.L. Hart, N. Noiseux, L. Zhang, F. Morello, S.D. Solomon, G.L. Stahl, R.E. Pratt, and V.J. Dzau Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury Proc. Natl. Acad. Sci. USA 101 2004 12282 12287
35. H. Su, S. Joho, Y. Huang, A. Barcena, J. Arakawa-Hoyt, W. Grossman, and Y.W. Kan Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts Proc. Natl. Acad. Sci. USA 101 2004 16280 16285
36. B.H. Choi, Y. Ha, C.H. Ahn, X. Huang, J.M. Kim, S.R. Park, H. Park, H.C. Park, S.W. Kim, and M. Lee A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury Neurosci. Lett. 412 2007 118 122
37. Q. Shi, P. Zhang, J. Zhang, X. Chen, H. Lu, Y. Tian, T.L. Parker, and Y. Liu Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice Neurosci. Lett. 465 2009 220 225
38. M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, and J. Telser Free radicals and antioxidants in normal physiological functions and human disease Int. J. Biochem. Cell Biol. 39 2007 44 84
39. T.W. Kensler, and N. Wakabayashi Nrf2: friend or foe for chemoprevention? Carcinogenesis 31 2010 90 99
40. B. Padmanabhan, K.I. Tong, T. Ohta, Y. Nakamura, M. Scharlock, M. Ohtsuji, M.I. Kang, A. Kobayashi, S. Yokoyama, and M. Yamamoto Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer Mol. Cell 21 2006 689 700
41. A. Singh, V. Misra, R.K. Thimmulappa, H. Lee, S. Ames, M.O. Hoque, J.G. Herman, S.B. Baylin, D. Sidransky, E. Gabrielson, M.V. Brock, and S. Biswal Dysfunctional Keap1-Nrf2 interaction in non-small-cell lung cancer PLoS Med. 3 2006 e420
42. A. Singh, M. Bodas, N. Wakabayashi, F. Bunz, and S. Biswal Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance Antioxid. Redox Signal. 13 2010 1627 1637
43. T. Jiang, N. Chen, F. Zhao, X.J. Wang, B. Kong, W. Zheng, and D.D. Zhang High levels of Nrf2 determine chemoresistance in type II endometrial cancer Cancer Res. 70 2010 5486 5496
44. P. Zhang, A. Singh, S. Yegnasubramanian, D. Esopi, P. Kombairaju, M. Bodas, H. Wu, S.G. Bova, and S. Biswal Loss of kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth Mol. Cancer Ther. 9 2010 336 346
45. C.V. Pecot, G.A. Calin, R.L. Coleman, G. Lopez-Berestein, and A.K. Sood RNA interference in the clinic: challenges and future directions Nat. Rev. Cancer 11 2011 59 67
46. B.E. Hast, D. Goldfarb, K.M. Mulvaney, M.A. Hast, P.F. Siesser, F. Yan, D.N. Hayes, and M.B. Major Proteomic analysis of ubiquitin ligase Keap1 reveals associated proteins that inhibit Nrf2 ubiquitination Cancer Res. 73 2013 2199 2210
47. J.T. Mendell, and E.N. Olson MicroRNAs in stress signaling and human disease Cell 148 2012 1172 1187
48. A. Namani, Y. Li, X.J. Wang, and X. Tang Modulation of Nrf2 signaling pathway by nuclear receptors: implications for cancer Biochim. Biophys. Acta 1843 2014 1875 1885
49. H.M. Leinonen, A.K. Ruotsalainen, A.M. Maatta, H.M. Laitinen, S.M. Kuosmanen, E. Kansanen, J.T. Pikkarainen, J.P. Lappalainen, H. Samaranayake, H.P. Lesch, M.U. Kaikkonen, S. Yla-Herttuala, and A.L. Levonen Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment Cancer Res. 72 2012 6227 6235
50. Cancer Genome Atlas Research Network Comprehensive genomic characterization of squamous cell lung cancers Nature 489 2012 519 525
51. Cancer Genome Atlas Research Network Comprehensive molecular profiling of lung adenocarcinoma Nature 511 2014 543 550
52. J. Emerit, M. Edeas, and F. Bricaire Neurodegenerative diseases and oxidative stress Biomed. Pharmacother. 58 2004 39 46
53. B. Uttara, A.V. Singh, P. Zamboni, and R.T. Mahajan Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options Curr. Neuropharmacol. 7 2009 65 74
54. J. Ruszkiewicz, and J. Albrecht Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders Neurochem. Int. 2015
55. D. Pratico Evidence of oxidative stress in alzheimer disease brain and antioxidant therapy: Lights and shadows Ann. N. Y. Acad. Sci. 1147 2008 70 78
56. Y. Zhao, and B. Zhao Oxidative stress and the pathogenesis of alzheimer disease Oxid. Med. Cell. Longev. 2013 2013 316523
57. Z. Chen, and C. Zhong Oxidative stress in alzheimer disease Neurosci. Bull. 30 2014 271 281
58. T. Persson, B.O. Popescu, and A. Cedazo-Minguez Oxidative stress in alzheimer disease: why did antioxidant therapy fail? Oxid. Med. Cell. Longev. 2014 2014 427318
59. M.E. Ferreira, A.S. de Vasconcelos, T. da Costa Vilhena, T.L. da Silva, A. da Silva Barbosa, A.R. Gomes, M.F. Dolabela, and S. Percario Oxidative stress in alzheimer disease: should we keep trying antioxidant therapies? Cell. Mol. Neurobiol. 2015
60. D.A. Drechsel, and M. Patel Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in parkinson disease Free Radic. Biol. Med. 44 2008 1873 1886
61. O. Weinreb, S. Mandel, M.B. Youdim, and T. Amit Targeting dysregulation of brain iron homeostasis in parkinson disease by iron chelators Free Radic. Biol. Med. 62 2013 52 64
62. G.S. Gaki, and A.G. Papavassiliou Oxidative stress-induced signaling pathways implicated in the pathogenesis of parkinson disease Neuromolecular Med. 16 2014 217 230
63. S.C. Barber, and P.J. Shaw Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target Free Radic. Biol. Med. 48 2010 629 641
64. E. D'Amico, P. Factor-Litvak, R.M. Santella, and H. Mitsumoto Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis Free Radic. Biol. Med. 65 2013 509 527
65. E. Pollari, G. Goldsteins, G. Bart, J. Koistinaho, and R. Giniatullin The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis Front. Cell. Neurosci. 8 2014 131
66. P. Vehvilainen, J. Koistinaho, and G. Gundars Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis Front. Cell. Neurosci. 8 2014 126
67. S.D. Chen, A.Y. Chang, and Y.C. Chuang The potential role of mitochondrial dysfunction in seizure-associated cell death in the hippocampus and epileptogenesis J. Bioenerg. Biomembr. 42 2010 461 465
68. S. Rowley, and M. Patel Mitochondrial involvement and oxidative stress in temporal lobe epilepsy Free Radic. Biol. Med. 62 2013 121 131
69. M. Mendez-Armenta, C. Nava-Ruiz, D. Juarez-Rebollar, E. Rodriguez-Martinez, and P.Y. Gomez Oxidative stress associated with neuronal apoptosis in experimental models of epilepsy Oxid. Med. Cell. Longev. 2014 2014 293689
70. E.D. Hall Antioxidant therapies for acute spinal cord injury Neurotherapeutics 8 2011 152 167
71. E.D. Hall, J.A. Wang, J.M. Bosken, and I.N. Singh Lipid peroxidation in brain or spinal cord mitochondria after injury J. Bioenerg. Biomembr. 2015
72. M. Bains, and E.D. Hall Antioxidant therapies in traumatic brain and spinal cord injury Biochim. Biophys. Acta 1822 2012 675 684
73. Z. Jia, H. Zhu, J. Li, X. Wang, H. Misra, and Y. Li Oxidative stress in spinal cord injury and antioxidant-based intervention Spinal Cord 50 2012 264 274
74. S. Manzanero, T. Santro, and T.V. Arumugam Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury Neurochem. Int. 62 2013 712 718
75. J. Zhao, N. Kobori, J. Aronowski, and P.K. Dash Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents Neurosci. Lett. 393 2006 108 112
76. J. Zhao, A.N. Moore, J.B. Redell, and P.K. Dash Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury J. Neurosci. 27 2007 10240 10248
77. H. Akhter, A. Katre, L. Li, X. Liu, and R.M. Liu Therapeutic potential and anti-amyloidosis mechanisms of tert-butylhydroquinone for alzheimer disease J. Alzheimers Dis. 26 2011 767 778
78. A.L. Benedict, A. Mountney, A. Hurtado, K.E. Bryan, R.L. Schnaar, A.T. Dinkova-Kostova, and P. Talalay Neuroprotective effects of sulforaphane after contusive spinal cord injury J. Neurotrauma 29 2012 2576 2586
79. F. Morroni, A. Tarozzi, G. Sita, C. Bolondi, J.M. Zolezzi Moraga, G. Cantelli-Forti, and P. Hrelia Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of parkinson disease Neurotoxicology 36 2013 63 71
80. W. Jin, H. Ni, X. Hou, X. Ming, J. Wang, B. Yuan, T. Zhu, J. Jiang, H. Wang, and W. Liang Tert-butylhydroquinone protects the spinal cord against inflammatory response produced by spinal cord injury Ann. Clin. Lab. Sci. 44 2014 151 157
81. Z. Wang, C. Ji, L. Wu, J. Qiu, Q. Li, Z. Shao, and G. Chen Tert-butylhydroquinone alleviates early brain injury and cognitive dysfunction after experimental subarachnoid hemorrhage: role of Keap1/Nrf2/ARE pathway PLoS One 9 2014 e97685
82. S. Ruggieri, C. Tortorella, and C. Gasperini Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis Ther. Clin. Risk Manag. 10 2014 229 239
83. K. Ding, H. Wang, J. Xu, T. Li, L. Zhang, Y. Ding, L. Zhu, J. He, and M. Zhou Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism Free Radic. Biol. Med. 73 2014 1 11
84. G. Negi, A. Kumar, and S.S. Sharma Nrf2 and NF-kappaB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes Curr. Neurovasc Res. 8 2011 294 304
85. S.A. Reddy, S.B. Shelar, T.M. Dang, B.N. Lee, H. Yang, S.M. Ong, H.L. Ng, W.K. Chui, S.C. Wong, and E.H. Chew Sulforaphane and its methylcarbonyl analogs inhibit the LPS-stimulated inflammatory response in human monocytes through modulating cytokine production, suppressing chemotactic migration and phagocytosis in a NF-kappaB- and MAPK-dependent manner Int. Immunopharmacol. 24 2015 440 450
86. G.E. Rooney, S.S. McMahon, T. Ritter, Y. Garcia, C. Moran, N.N. Madigan, A. Flugel, P. Dockery, T. O'Brien, L. Howard, A.J. Windebank, and F.P. Barry Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells Tissue Eng. Part A 15 2009 3049 3059
87. Y. Chen, Y. Tang, L.C. Vogel, and M.J. Devivo Causes of spinal cord injury Top. Spinal Cord. Inj. Rehabil. 19 2013 1 8
88. C.H. Tator Update on the pathophysiology and pathology of acute spinal cord injury Brain Pathol. 5 1995 407 413
89. J.W. Rowland, G.W. Hawryluk, B. Kwon, and M.G. Fehlings Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon Neurosurg. Focus 25 2008 E2
90. N.A. Silva, N. Sousa, R.L. Reis, and A.J. Salgado From basics to clinical: a comprehensive review on spinal cord injury Prog. Neurobiol. 114 2014 25 57
91. C.A. Oyinbo Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade Acta Neurobiol. Exp. (Wars.) 71 2011 281 299
92. E.D. Hall, and J.M. Braughler Central nervous system trauma and stroke. II. physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation Free Radic. Biol. Med. 6 1989 303 313
93. N.E. Bastani, E. Kostovski, A.K. Sakhi, A. Karlsen, M.H. Carlsen, N. Hjeltnes, R. Blomhoff, and P.O. Iversen Reduced antioxidant defense and increased oxidative stress in spinal cord injured patients Arch. Phys. Med. Rehabil. 93 e2 2012 2223 2228
94. L. Mao, H.D. Wang, X.L. Wang, L. Tian, and J.Y. Xu Disruption of Nrf2 exacerbated the damage after spinal cord injury in mice J. Trauma. Acute Care. Surg. 72 2012 189 198
95. X. Wang, J.P. de Rivero Vaccari, H. Wang, P. Diaz, R. German, A.E. Marcillo, and R.W. Keane Activation of the nuclear factor E2-related factor 2/antioxidant response element pathway is neuroprotective after spinal cord injury J. Neurotrauma 29 2012 936 945
96. Y. Pomeshchik, I. Kidin, E. Savchenko, T. Rolova, M. Yamamoto, A.L. Levonen, S. Yla-Herttuala, T. Malm, K. Kanninen, and J. Koistinaho Does Nrf2 gene transfer facilitate recovery after contusion spinal cord injury? Antioxid. Redox Signal. 20 2014 1313 1323
97. L. Mao, H. Wang, X. Wang, H. Liao, and X. Zhao Transcription factor Nrf2 protects the spinal cord from inflammation produced by spinal cord injury J. Surg. Res. 170 2011 e105 e115
98. D.M. Basso, L.C. Fisher, A.J. Anderson, L.B. Jakeman, D.M. McTigue, and P.G. Popovich Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains J. Neurotrauma 23 2006 635 659
99. D.A. Johnson, S. Amirahmadi, C. Ward, Z. Fabry, and J.A. Johnson The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis Toxicol. Sci. 114 2010 237 246
100. I. Pineau, and S. Lacroix Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved J. Comp. Neurol. 500 2007 267 285
101. H. Pan, H. Wang, X. Wang, L. Zhu, and L. Mao The absence of Nrf2 enhances NF-kappaB-dependent inflammation following scratch injury in mouse primary cultured astrocytes Mediators Inflamm. 2012 2012 217580
102. L. Mao, H. Wang, L. Qiao, and X. Wang Disruption of Nrf2 enhances the upregulation of nuclear factor-kappaB activity, tumor necrosis factor-alpha, and matrix metalloproteinase-9 after spinal cord injury in mice Mediators Inflamm. 2010 2010 238321
103. S. Hisahara, S. Shoji, H. Okano, and M. Miura ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor J. Neurochem. 69 1997 10 20
104. T. Genovese, E. Mazzon, C. Crisafulli, R. Di Paola, C. Muia, E. Esposito, P. Bramanti, and S. Cuzzocrea TNF-alpha blockage in a mouse model of SCI: Evidence for improved outcome Shock 29 2008 32 41
105. T. Genovese, E. Esposito, E. Mazzon, R. Di Paola, R. Caminiti, P. Bramanti, A. Cappelani, and S. Cuzzocrea Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice J. Neurochem. 108 2009 1360 1372
106. W. Yan, H.D. Wang, Z.G. Hu, Q.F. Wang, and H.X. Yin Activation of Nrf2-ARE pathway in brain after traumatic brain injury Neurosci. Lett. 431 2008 150 154
107. W. Yan, H.D. Wang, X.M. Feng, Y.S. Ding, W. Jin, and K. Tang The expression of NF-E2-related factor 2 in the rat brain after traumatic brain injury J. Trauma 66 2009 1431 1435
108. M. Chen, and R.F. Regan Time course of increased heme oxygenase activity and expression after experimental intracerebral hemorrhage: correlation with oxidative injury J. Neurochem. 103 2007 2015 2021
109. N. Tanaka, Y. Ikeda, Y. Ohta, K. Deguchi, F. Tian, J. Shang, T. Matsuura, and K. Abe Expression of Keap1-Nrf2 system and antioxidative proteins in mouse brain after transient middle cerebral artery occlusion Brain Res. 1370 2011 246 253
110. W. Jin, H. Wang, W. Yan, L. Zhu, Z. Hu, Y. Ding, and K. Tang Role of Nrf2 in protection against traumatic brain injury in mice J. Neurotrauma 26 2009 131 139
111. Y. Hong, W. Yan, S. Chen, C.R. Sun, and J.M. Zhang The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice Acta Pharmacol. Sin. 31 2010 1421 1430
112. A.Y. Shih, S. Imbeault, V. Barakauskas, H. Erb, L. Jiang, P. Li, and T.H. Murphy Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo J. Biol. Chem. 280 2005 22925 22936
113. Z.A. Shah, R.C. Li, R.K. Thimmulappa, T.W. Kensler, M. Yamamoto, S. Biswal, and S. Dore Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury Neuroscience 147 2007 53 59
114. T. Li, H. Wang, Y. Ding, M. Zhou, X. Zhou, X. Zhang, K. Ding, J. He, X. Lu, J. Xu, and W. Wei Genetic elimination of Nrf2 aggravates secondary complications except for vasospasm after experimental subarachnoid hemorrhage in mice Brain Res. 1558 2014 90 99
115. V. Karkkainen, Y. Pomeshchik, E. Savchenko, H. Dhungana, A. Kurronen, S. Lehtonen, N. Naumenko, P. Tavi, A.L. Levonen, M. Yamamoto, T. Malm, J. Magga, K.M. Kanninen, and J. Koistinaho Nrf2 regulates neurogenesis and protects neural progenitor cells against abeta toxicity Stem Cells 32 2014 1904 1916
116. W. Xiong, A.E. MacColl Garfinkel, Y. Li, L.I. Benowitz, and C.L. Cepko Nrf2 promotes neuronal survival in neurodegeneration and acute nerve damage J. Clin. Invest. 125 2015 1433 1445
117. M.M. Mielke, P. Vemuri, and W.A. Rocca Clinical epidemiology of alzheimer disease: Assessing sex and gender differences Clin. Epidemiol. 6 2014 37 48
118. H.W. Querfurth, and F.M. LaFerla Alzheimer disease N. Engl. J. Med. 362 2010 329 344
119. C. Reitz, and R. Mayeux Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers Biochem. Pharmacol. 88 2014 640 651
120. D.J. Selkoe Alzheimer disease Cold Spring Harb Perspect. Biol. 3 2011 10.1101/cshperspect.a004457
121. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P.K. Jones, H. Ghanbari, T. Wataya, S. Shimohama, S. Chiba, C.S. Atwood, R.B. Petersen, and M.A. Smith Oxidative damage is the earliest event in alzheimer disease J. Neuropathol. Exp. Neurol. 60 2001 759 767
122. L. Chen, R. Na, M. Gu, A. Richardson, and Q. Ran Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in alzheimer disease J. Neurochem. 107 2008 197 207
123. T. Kanamaru, N. Kamimura, T. Yokota, K. Iuchi, K. Nishimaki, S. Takami, H. Akashiba, Y. Shitaka, K. Katsura, K. Kimura, and S. Ohta Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of alzheimer disease Neurosci. Lett. 587 2015 126 131
124. T.C. Gamblin, M.E. King, J. Kuret, R.W. Berry, and L.I. Binder Oxidative regulation of fatty acid-induced tau polymerization Biochemistry 39 2000 14203 14210
125. S. Melov, P.A. Adlard, K. Morten, F. Johnson, T.R. Golden, D. Hinerfeld, B. Schilling, C. Mavros, C.L. Masters, I. Volitakis, Q.X. Li, K. Laughton, A. Hubbard, R.A. Cherny, B. Gibson, and A.I. Bush Mitochondrial oxidative stress causes hyperphosphorylation of tau PLoS One 2 2007 e536
126. G. Joshi, K.A. Gan, D.A. Johnson, and J.A. Johnson Increased alzheimer disease-like pathology in the APP/ PS1DeltaE9 mouse model lacking Nrf2 through modulation of autophagy Neurobiol. Aging 36 2015 664 679
127. C.P. Ramsey, C.A. Glass, M.B. Montgomery, K.A. Lindl, G.P. Ritson, L.A. Chia, R.L. Hamilton, C.T. Chu, and K.L. Jordan-Sciutto Expression of Nrf2 in neurodegenerative diseases J. Neuropathol. Exp. Neurol. 66 2007 75 85
128. F. Choudhry, D.R. Howlett, J.C. Richardson, P.T. Francis, and R.J. Williams Pro-oxidant diet enhances beta/gamma secretase-mediated APP processing in APP/PS1 transgenic mice Neurobiol. Aging 33 2012 960 968
129. W. Wang, Y. Wu, G. Zhang, H. Fang, H. Wang, H. Zang, T. Xie, and W. Wang Activation of Nrf2-ARE signal pathway protects the brain from damage induced by epileptic seizure Brain Res. 1544 2014 54 61
130. A. Benraiss, and S.A. Goldman Cellular therapy and induced neuronal replacement for huntington disease Neurotherapeutics 8 2011 577 590
131. O. Lindvall Dopaminergic neurons for parkinson therapy Nat. Biotechnol. 30 2012 56 58
132. G.H. Petit, T.T. Olsson, and P. Brundin The future of cell therapies and brain repair: Parkinson disease leads the way Neuropathol. Appl. Neurobiol. 40 2014 60 70
133. C.R. Freed, P.E. Greene, R.E. Breeze, W.Y. Tsai, W. DuMouchel, R. Kao, S. Dillon, H. Winfield, S. Culver, J.Q. Trojanowski, D. Eidelberg, and S. Fahn Transplantation of embryonic dopamine neurons for severe parkinson disease N. Engl. J. Med. 344 2001 710 719
134. C.W. Olanow, C.G. Goetz, J.H. Kordower, A.J. Stoessl, V. Sossi, M.F. Brin, K.M. Shannon, G.M. Nauert, D.P. Perl, J. Godbold, and T.B. Freeman A double-blind controlled trial of bilateral fetal nigral transplantation in parkinson disease Ann. Neurol. 54 2003 403 414
135. Z. Kefalopoulou, M. Politis, P. Piccini, N. Mencacci, K. Bhatia, M. Jahanshahi, H. Widner, S. Rehncrona, P. Brundin, A. Bjorklund, O. Lindvall, P. Limousin, N. Quinn, and T. Foltynie Long-term clinical outcome of fetal cell transplantation for parkinson disease: two case reports JAMA Neurol. 71 2014 83 87
136. L.M. Tong, H. Fong, and Y. Huang Stem cell therapy for alzheimer disease and related disorders: current status and future perspectives Exp. Mol. Med. 47 e151 2015
137. S.S. Choi, S.R. Lee, S.U. Kim, and H.J. Lee Alzheimer disease and stem cell therapy Exp. Neurobiol. 23 2014 45 52
138. J. Tang, H. Xu, X. Fan, D. Li, D. Rancourt, G. Zhou, Z. Li, and L. Yang Embryonic stem cell-derived neural precursor cells improve memory dysfunction in abeta(1-40) injured rats Neurosci. Res. 62 2008 86 96
139. M. Blurton-Jones, M. Kitazawa, H. Martinez-Coria, N.A. Castello, F.J. Muller, J.F. Loring, T.R. Yamasaki, W.W. Poon, K.N. Green, and F.M. Laferla Neural stem cells improve cognition via BDNF in a transgenic model of alzheimer disease Proc. Natl. Acad. Sci. USA 2009
140. D. Park, H.J. Lee, S.S. Joo, D.K. Bae, G. Yang, Y.H. Yang, I. Lim, A. Matsuo, I. Tooyama, Y.B. Kim, and S.U. Kim Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunction Exp. Neurol. 234 2012 521 526
141. W. Zhang, G.M. Wang, P.J. Wang, Q. Zhang, and S.H. Sha Effects of neural stem cells on synaptic proteins and memory in a mouse model of alzheimer disease J. Neurosci. Res. 92 2014 185 194
142. H.M. Yun, H.S. Kim, K.R. Park, J.M. Shin, A.R. Kang, K. il Lee, S. Song, Y.B. Kim, S.B. Han, H.M. Chung, and J.T. Hong Placenta-derived mesenchymal stem cells improve memory dysfunction in an Abeta1-42-infused mouse model of alzheimer disease Cell. Death Dis. 4 2013 e958
143. N.V. Bobkova, R.A. Poltavtseva, A.N. Samokhin, and G.T. Sukhikh Therapeutic effect of mesenchymal multipotent stromal cells on memory in animals with alzheimer-type neurodegeneration Bull. Exp. Biol. Med. 156 2013 119 121
144. G. Gu, W. Zhang, M. Li, J. Ni, and P. Wang Transplantation of NSC-derived cholinergic neuron-like cells improves cognitive function in APP/PS1 transgenic mice Neuroscience 291C 2015 81 92
145. K.A. Chang, H.J. Kim, Y. Joo, S. Ha, and Y.H. Suh The therapeutic effects of human adipose-derived stem cells in alzheimer disease mouse models Neurodegener Dis. 13 2014 99 102
146. L.M. Tong, B. Djukic, C. Arnold, A.K. Gillespie, S.Y. Yoon, M.M. Wang, O. Zhang, J. Knoferle, J.L. Rubenstein, A. Alvarez-Buylla, and Y. Huang Inhibitory interneuron progenitor transplantation restores normal learning and memory in ApoE4 knock-in mice without or with abeta accumulation J. Neurosci. 34 2014 9506 9515
147. H.E. Marei, A. Farag, A. Althani, N. Afifi, A. Abd-Elmaksoud, S. Lashen, S. Rezk, R. Pallini, P. Casalbore, and C. Cenciarelli Human olfactory bulb neural stem cells expressing hNGF restore cognitive deficit in alzheimer disease rat model J. Cell. Physiol. 230 2015 116 130
148. H.V. Kim, H.Y. Kim, H.Y. Ehrlich, S.Y. Choi, D.J. Kim, and Y. Kim Amelioration of alzheimer disease by neuroprotective effect of sulforaphane in animal model Amyloid 20 2013 7 12
149. T. Ma, K. Gong, Q. Ao, Y. Yan, B. Song, H. Huang, X. Zhang, and Y. Gong Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in alzheimer disease mice Cell Transplant. 22 Suppl. 1 2013 S113 S126
150. K.A. Chang, J.H. Lee, and Y.H. Suh Therapeutic potential of human adipose-derived stem cells in neurological disorders J. Pharmacol. Sci. 126 2014 293 301
151. D. Darlington, J. Deng, B. Giunta, H. Hou, C.D. Sanberg, N. Kuzmin-Nichols, H.D. Zhou, T. Mori, J. Ehrhart, P.R. Sanberg, and J. Tan Multiple low-dose infusions of human umbilical cord blood cells improve cognitive impairments and reduce amyloid-beta-associated neuropathology in alzheimer mice Stem Cells Dev. 22 2013 412 421
152. H. Yang, Z. Xie, L. Wei, H. Yang, S. Yang, Z. Zhu, P. Wang, C. Zhao, and J. Bi Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AbetaPP/PS1 transgenic mouse model Stem Cell. Res. Ther. 4 2013 76
153. Z. Kazmerova, N. Zilka, M. Cente, P. Neradil, M. Zilkova, and M. Novak Can we teach old dogs new tricks? neuroprotective cell therapy in alzheimer and parkinson disease J. Alzheimers Dis. 37 2013 251 272
154. S.U. Kim, H.J. Lee, and Y.B. Kim Neural stem cell-based treatment for neurodegenerative diseases Neuropathology 33 2013 491 504
155. X. Liu, R. Ye, T. Yan, S.P. Yu, L. Wei, G. Xu, X. Fan, Y. Jiang, R.A. Stetler, G. Liu, and J. Chen Cell based therapies for ischemic stroke: from basic science to bedside Prog. Neurobiol. 115 2014 92 115
156. D. Kalladka, and K.W. Muir Brain repair: cell therapy in stroke Stem Cells Cloning 7 2014 31 44
157. D.M. Hermann, L. Peruzzotti-Jametti, J. Schlechter, J.D. Bernstock, T.R. Doeppner, and S. Pluchino Neural precursor cells in the ischemic brain - integration, cellular crosstalk, and consequences for stroke recovery Front. Cell. Neurosci. 8 2014 291
158. L. Hao, Z. Zou, H. Tian, Y. Zhang, H. Zhou, and L. Liu Stem cell-based therapies for ischemic stroke Biomed. Res. Int. 2014 2014 468748
159. A.J. Mothe, and C.H. Tator Review of transplantation of neural stem/progenitor cells for spinal cord injury Int. J. Dev. Neurosci. 31 2013 701 713
160. R. Vawda, and M.G. Fehlings Mesenchymal cells in the treatment of spinal cord injury: current & future perspectives Curr. Stem Cell. Res. Ther. 8 2013 25 38
161. V.R. Dasari, K.K. Veeravalli, and D.H. Dinh Mesenchymal stem cells in the treatment of spinal cord injuries: a review World J. Stem Cells 6 2014 120 133
162. M.G. Fehlings, and R. Vawda Cellular treatments for spinal cord injury: the time is right for clinical trials Neurotherapeutics 8 2011 704 720
163. K.C. Roet, and J. Verhaagen Understanding the neural repair-promoting properties of olfactory ensheathing cells Exp. Neurol. 261 2014 594 609
164. F. Feron, C. Perry, J. Cochrane, P. Licina, A. Nowitzke, S. Urquhart, T. Geraghty, and A. Mackay-Sim Autologous olfactory ensheathing cell transplantation in human spinal cord injury Brain 128 2005 2951 2960
165. A. Mackay-Sim, F. Feron, J. Cochrane, L. Bassingthwaighte, C. Bayliss, W. Davies, P. Fronek, C. Gray, G. Kerr, P. Licina, A. Nowitzke, C. Perry, P.A. Silburn, S. Urquhart, and T. Geraghty Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial Brain 131 2008 2376 2386
166. H. Saberi, P. Moshayedi, H.R. Aghayan, B. Arjmand, S.K. Hosseini, S.H. Emami-Razavi, V. Rahimi-Movaghar, M. Raza, and M. Firouzi Treatment of chronic thoracic spinal cord injury patients with autologous schwann cell transplantation: an interim report on safety considerations and possible outcomes Neurosci. Lett. 443 2008 46 50
167. P. Tabakow, W. Jarmundowicz, B. Czapiga, W. Fortuna, R. Miedzybrodzki, M. Czyz, J. Huber, D. Szarek, S. Okurowski, P. Szewczyk, A. Gorski, and G. Raisman Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury Cell Transplant. 22 2013 1591 1612
168. J. Lebkowski GRNOPC1: the world first embryonic stem cell-derived therapy. interview with jane lebkowski Regen. Med. 6 2011 11 13
169. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
170. V.B. Mattis, and C.N. Svendsen Induced pluripotent stem cells: a new revolution for clinical neurology? Lancet Neurol. 10 2011 383 394
171. Y. Zhang, C. Pak, Y. Han, H. Ahlenius, Z. Zhang, S. Chanda, S. Marro, C. Patzke, C. Acuna, J. Covy, W. Xu, N. Yang, T. Danko, L. Chen, M. Wernig, and T.C. Sudhof Rapid single-step induction of functional neurons from human pluripotent stem cells Neuron 78 2013 785 798
172. X. Yuan, H. Wan, X. Zhao, S. Zhu, Q. Zhou, and S. Ding Brief report: combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts Stem Cells 29 2011 549 553
173. S.K. Mallanna, and A. Rizzino Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells Dev. Biol. 344 2010 16 25
174. J. Polentes, P. Jendelova, M. Cailleret, H. Braun, N. Romanyuk, P. Tropel, M. Brenot, V. Itier, C. Seminatore, K. Baldauf, K. Turnovcova, D. Jirak, M. Teletin, J. Come, J. Tournois, K. Reymann, E. Sykova, S. Viville, and B. Onteniente Human induced pluripotent stem cells improve stroke outcome and reduce secondary degeneration in the recipient brain Cell Transplant. 21 2012 2587 2602
175. O. Mohamad, D. Drury-Stewart, M. Song, B. Faulkner, D. Chen, S.P. Yu, and L. Wei Vector-free and transgene-free human iPS cells differentiate into functional neurons and enhance functional recovery after ischemic stroke in mice PLoS One 8 2013 e64160
176. S.H. Yuan, and M. Shaner Bioengineered stem cells in neural development and neurodegeneration research Ageing Res. Rev. 12 2013 739 748
177. D. Tornero, S. Wattananit, M. Gronning Madsen, P. Koch, J. Wood, J. Tatarishvili, Y. Mine, R. Ge, E. Monni, K. Devaraju, R.F. Hevner, O. Brustle, O. Lindvall, and Z. Kokaia Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery Brain 136 2013 3561 3577
178. J. Tatarishvili, K. Oki, E. Monni, P. Koch, T. Memanishvili, A.M. Buga, V. Verma, A. Popa-Wagner, O. Brustle, O. Lindvall, and Z. Kokaia Human induced pluripotent stem cells improve recovery in stroke-injured aged rats Restor. Neurol. Neurosci. 32 2014 547 558
179. S. Nori, Y. Okada, A. Yasuda, O. Tsuji, Y. Takahashi, Y. Kobayashi, K. Fujiyoshi, M. Koike, Y. Uchiyama, E. Ikeda, Y. Toyama, S. Yamanaka, M. Nakamura, and H. Okano Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice Proc. Natl. Acad. Sci. USA 108 2011 16825 16830
180. Y. Fujimoto, M. Abematsu, A. Falk, K. Tsujimura, T. Sanosaka, B. Juliandi, K. Semi, M. Namihira, S. Komiya, A. Smith, and K. Nakashima Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells Stem Cells 30 2012 1163 1173
181. Y. Kobayashi, Y. Okada, G. Itakura, H. Iwai, S. Nishimura, A. Yasuda, S. Nori, K. Hikishima, T. Konomi, K. Fujiyoshi, O. Tsuji, Y. Toyama, S. Yamanaka, M. Nakamura, and H. Okano Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity PLoS One 7 2012 e52787
182. P. Lu, G. Woodruff, Y. Wang, L. Graham, M. Hunt, D. Wu, E. Boehle, R. Ahmad, G. Poplawski, J. Brock, L.S. Goldstein, and M.H. Tuszynski Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury Neuron 83 2014 789 796
183. N. Romanyuk, T. Amemori, K. Turnovcova, P. Prochazka, B. Onteniente, E. Sykova, and P. Jendelova Beneficial effect of human induced pluripotent stem cell-derived neural precursors in spinal cord injury repair Cell Transplant. 2014
184. D. Cyranoski Stem cells cruise to clinic Nature 494 2013 413
185. A. Nowakowski, A. Andrzejewska, M. Janowski, P. Walczak, and B. Lukomska Genetic engineering of stem cells for enhanced therapy Acta Neurobiol. Exp. (Wars.) 73 2013 1 18
186. D.H. Hwang, S.R. Jeong, and B.G. Kim Gene transfer mediated by stem cell grafts to treat CNS injury Expert Opin. Biol. Ther. 11 2011 1599 1610
187. O. Ben-Menachem-Zidon, Y. Ben-Menahem, T. Ben-Hur, and R. Yirmiya Intra-hippocampal transplantation of neural precursor cells with transgenic over-expression of IL-1 receptor antagonist rescues memory and neurogenesis impairments in an alzheimer disease model Neuropsychopharmacology 39 2014 401 414
188. M.J. Calkins, M.R. Vargas, D.A. Johnson, and J.A. Johnson Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition Toxicol. Sci. 115 2010 557 568
189. J. Li, D. Johnson, M. Calkins, L. Wright, C. Svendsen, and J. Johnson Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells Toxicol. Sci. 83 2005 313 328
190. H. Sakata, K. Niizuma, H. Yoshioka, G.S. Kim, J.E. Jung, M. Katsu, P. Narasimhan, C.M. Maier, Y. Nishiyama, and P.H. Chan Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats J. Neurosci. 32 2012 3462 3473
191. Y.S. Malik, M.A. Sheikh, and X. Zhu Doxycycline can stimulate cytoprotection in neural stem cells with oxygen-glucose deprivation-reoxygenation injury: A potential approach to enhance effectiveness of cell transplantation therapy Biochem. Biophys. Res. Commun. 432 2013 355 358
192. H. Suh, W. Deng, and F.H. Gage Signaling in adult neurogenesis Annu. Rev. Cell Dev. Biol. 25 2009 253 275
193. O. Lazarov, M.P. Mattson, D.A. Peterson, S.W. Pimplikar, and H. van Praag When neurogenesis encounters aging and disease Trends Neurosci. 33 2010 569 579
194. Y. Mu, and F.H. Gage Adult hippocampal neurogenesis and its role in alzheimer disease Mol. Neurodegener. 6 2011 85-1326-6-85
195. M.K. Tobin, J.A. Bonds, R.D. Minshall, D.A. Pelligrino, F.D. Testai, and O. Lazarov Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here J. Cereb. Blood Flow Metab. 34 2014 1573 1584
196. T.D. Merson, and J.A. Bourne Endogenous neurogenesis following ischaemic brain injury: insights for therapeutic strategies Int. J. Biochem. Cell Biol. 56 2014 4 19
197. K. Meletis, F. Barnabe-Heider, M. Carlen, E. Evergren, N. Tomilin, O. Shupliakov, and J. Frisen Spinal cord injury reveals multilineage differentiation of ependymal cells PLoS Biol. 6 2008 e182
198. F. Barnabe-Heider, C. Goritz, H. Sabelstrom, H. Takebayashi, F.W. Pfrieger, K. Meletis, and J. Frisen Origin of new glial cells in intact and injured adult spinal cord Cell. Stem Cell 7 2010 470 482
199. H. Sabelstrom, M. Stenudd, and J. Frisen Neural stem cells in the adult spinal cord Exp. Neurol. 260 2014 44 49
200. S. Lacroix, L.K. Hamilton, A. Vaugeois, S. Beaudoin, C. Breault-Dugas, I. Pineau, S.A. Levesque, C.A. Gregoire, and K.J. Fernandes Central canal ependymal cells proliferate extensively in response to traumatic spinal cord injury but not demyelinating lesions PLoS One 9 2014 e85916
201. F. Zhao, T. Wu, A. Lau, T. Jiang, Z. Huang, X.J. Wang, W. Chen, P.K. Wong, and D.D. Zhang Nrf2 promotes neuronal cell differentiation Free Radic. Biol. Med. 47 2009 867 879
202. G.H. Danet, Y. Pan, J.L. Luongo, D.A. Bonnet, and M.C. Simon Expansion of human SCID-repopulating cells under hypoxic conditions J. Clin. Invest. 112 2003 126 135
203. T. Ezashi, P. Das, and R.M. Roberts Low O2 tensions and the prevention of differentiation of hES cells Proc. Natl. Acad. Sci. USA 102 2005 4783 4788
204. N. Wakabayashi, S. Shin, S.L. Slocum, E.S. Agoston, J. Wakabayashi, M.K. Kwak, V. Misra, S. Biswal, M. Yamamoto, and T.W. Kensler Regulation of notch1 signaling by nrf2: implications for tissue regeneration Sci. Signal. 3 2010 ra52
205. I. Imayoshi, M. Sakamoto, M. Yamaguchi, K. Mori, and R. Kageyama Essential roles of notch signaling in maintenance of neural stem cells in developing and adult brains J. Neurosci. 30 2010 3489 3498
206. S. Hitoshi, T. Alexson, V. Tropepe, D. Donoviel, A.J. Elia, J.S. Nye, R.A. Conlon, T.W. Mak, A. Bernstein, and D. van der Kooy Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells Genes Dev. 16 2002 846 858
207. S.F. Leiser, and R.A. Miller Nrf2 signaling, a mechanism for cellular stress resistance in long-lived mice Mol. Cell. Biol. 30 2010 871 884
208. F. L'Episcopo, C. Tirolo, N. Testa, S. Caniglia, M.C. Morale, F. Impagnatiello, S. Pluchino, and B. Marchetti Aging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3K-wnt/beta-catenin dysregulation J. Neurosci. 33 2013 1462 1485
209. D. Mittal, A. Ali, S. Md, S. Baboota, J.K. Sahni, and J. Ali Insights into direct nose to brain delivery: current status and future perspective Drug Deliv. 21 2014 75 86
210. M. Bourdenx, N. Dutheil, E. Bezard, and B. Dehay Systemic gene delivery to the central nervous system using adeno-associated virus Front. Mol. Neurosci. 7 2014 50
211. P. Zavattari, A. Perra, S. Menegon, M.A. Kowalik, A. Petrelli, M.M. Angioni, A. Follenzi, L. Quagliata, G.M. Ledda-Columbano, L. Terracciano, S. Giordano, and A. Columbano Nrf2, but not beta-catenin, mutation represents an early event in rat hepatocarcinogenesis Hepatology 2015